Guardant Health
GH
#1093
Rank
ยฃ16.68 B
Marketcap
ยฃ125.83
Share price
-1.63%
Change (1 day)
246.54%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): -ยฃ2.52

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -ยฃ2.54. In 2025 the company made an earnings per share (EPS) of -ยฃ2.48 an increase over its 2024 EPS that were of -ยฃ2.67.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ2.521.53%
2025-ยฃ2.48-7.02%
2024-ยฃ2.67-16.82%
2023-ยฃ3.21-33.13%
2022-ยฃ4.7960%
2021-ยฃ3.0055.04%
2020-ยฃ1.93207.14%
2019-ยฃ0.63-19.81%
2018-ยฃ0.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-ยฃ2.10-17.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-ยฃ1.86-26.84%๐Ÿ‡บ๐Ÿ‡ธ USA